Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barbui

Showing results (101-110 of 380) with videos related to

Pageof 38
Sort By:
Panminerva Medica|September 1, 1974
Platelet functions in von Willebrand's diseaseT Barbui, R Battista, M Cazzavillan, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1982
Diagnostic and prognostic significance of platelet-bound IgG measurement in immune thrombocytopenic purpuraT Barbui, S Cortelazzo, C Casarotto, et al.
Blood Cancer Journal|February 3, 2016
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisT Barbui, J Thiele, A M Vannucchi, et al.
Minerva Medica|July 14, 1970
[Experience with clinical therapy of diabetes mellitus with oral administration of combined chlorpropamide and phenylbiguanide]G Previato, T Barbui, G Cartei, et al.
Blood|July 15, 1995
Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodiesM Galli, G Finazzi, E M Bevers, et al.
Thrombosis and Haemostasis|October 31, 1984
L-asparaginase lowers protein C antigenT Barbui, G Finazzi, S Viganò, et al.
Leukemia|January 21, 2014
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasmsA Tefferi, J Thiele, A M Vannucchi, et al.
Thrombosis Research|April 1, 1987
Fibrinogen Bergamo III and fibrinogen Torino: two further variants with hereditary molecular defects in fibrinopeptide AP Reber, M Furlan, E A Beck, et al.
La Ricerca in Clinica E in Laboratorio|July 1, 1984
Abnormal reactivity with thrombin of a new variant of dysfunctional antithrombin (AT 'Vicenza')G Finazzi, T Barbui, T H Tran, et al.
Leukemia|March 8, 2013
Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemiaT Barbui, J Thiele, A M Vannucchi, et al.
Pageof 38

Showing results (101-110 of 380) with videos related to

Sort By:
Pageof 38
Panminerva Medica|September 1, 1974
Platelet functions in von Willebrand's diseaseT Barbui, R Battista, M Cazzavillan, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1982
Diagnostic and prognostic significance of platelet-bound IgG measurement in immune thrombocytopenic purpuraT Barbui, S Cortelazzo, C Casarotto, et al.
Blood Cancer Journal|February 3, 2016
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisT Barbui, J Thiele, A M Vannucchi, et al.
Minerva Medica|July 14, 1970
[Experience with clinical therapy of diabetes mellitus with oral administration of combined chlorpropamide and phenylbiguanide]G Previato, T Barbui, G Cartei, et al.
Blood|July 15, 1995
Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodiesM Galli, G Finazzi, E M Bevers, et al.
Thrombosis and Haemostasis|October 31, 1984
L-asparaginase lowers protein C antigenT Barbui, G Finazzi, S Viganò, et al.
Leukemia|January 21, 2014
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasmsA Tefferi, J Thiele, A M Vannucchi, et al.
Thrombosis Research|April 1, 1987
Fibrinogen Bergamo III and fibrinogen Torino: two further variants with hereditary molecular defects in fibrinopeptide AP Reber, M Furlan, E A Beck, et al.
La Ricerca in Clinica E in Laboratorio|July 1, 1984
Abnormal reactivity with thrombin of a new variant of dysfunctional antithrombin (AT 'Vicenza')G Finazzi, T Barbui, T H Tran, et al.
Leukemia|March 8, 2013
Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemiaT Barbui, J Thiele, A M Vannucchi, et al.
Pageof 38